NanoString Technologies Highlights Advances in Precision Oncology at the 60th Annual Meeting of the American Society of Hematology
29 nov. 2018 06h00 HE
|
NanoString Technologies, Inc.
SEATTLE, Nov. 29, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString to Present at the Evercore ISI HEALTHCONx Conference
20 nov. 2018 06h00 HE
|
NanoString Technologies, Inc.
SEATTLE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Technologies Releases Operating Results for Third Quarter of 2018
08 nov. 2018 16h01 HE
|
NanoString Technologies, Inc.
SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported...
NanoString Announces Launch of CAR-T Characterization Panel for use in Development and Manufacturing
08 nov. 2018 06h00 HE
|
NanoString Technologies, Inc.
SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
07 nov. 2018 16h09 HE
|
NanoString Technologies, Inc.
Includes Data from More than Twenty-Five Studies, Including Six Using GeoMx Digital Spatial Profiler SEATTLE, Nov. 07, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a...
NanoString to Present at the 2018 Canaccord Medical Technologies and Diagnostics Forum
05 nov. 2018 06h00 HE
|
NanoString Technologies, Inc.
SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Highlights Advances in Product Pipeline and Application Development at the 2018 Association of Molecular Pathology Conference
30 oct. 2018 06h00 HE
|
NanoString Technologies, Inc.
Demonstrates Potential of Hyb & Seq NGS Platform for Infectious Disease Applications SEATTLE, Oct. 30, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life...
MacroGenics and NanoString Enter Translational Research Collaboration to Identify and Develop Biomarkers in Immuno-Oncology
29 oct. 2018 06h00 HE
|
NanoString Technologies, Inc.
Translational Research Initiative Will Use PanCancer IO 360 Panel to Identify Predictive Signatures for MGD013 SEATTLE, Oct. 29, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc....
NanoString Announces $100 Million Term Loan Facility with CRG
15 oct. 2018 09h00 HE
|
NanoString Technologies, Inc.
SEATTLE, Oct. 15, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
Landmark Publications in Nature Medicine use NanoString’s Digital Spatial Profiling Platform to Discover Novel Insights in Immuno-Oncology
08 oct. 2018 16h01 HE
|
NanoString Technologies, Inc.
Two Independent Studies Use the GeoMx Digital Spatial Profiler to Investigate the Role of the Tumor and Micro-environment in Immunotherapy Response SEATTLE, Oct. 08, 2018 (GLOBE NEWSWIRE) --...